000			03919nam a22005897a 4500
008			150313s20142014 xxu||||| |||| 00| 0 eng d
022			_a0002-9343
040			_aOvid MEDLINE(R)
099			_a24859718
245			_aBalloon mitral valvuloplasty in the United States: a 13-year perspective.
251			_aAmerican Journal of Medicine. 127(11):1126.e1-12, 2014 Nov.
252			_aAm J Med. 127(11):1126.e1-12, 2014 Nov.
253			_aThe American journal of medicine
260			_c2014
260			_fFY2015
266			_d2015-03-17
501			_aAvailable online from MWHC library: 1995 - present, Available in print through MWHC library: 1999 - present
520			_aBACKGROUND: Incidence and prevalence of mitral stenosis is declining in the US. We performed this study to determine recent trends in utilization, complications, mortality, length of stay, and cost associated with balloon mitral valvuloplasty.
520			_aCONCLUSIONS: In a large cross-sectional study of balloon mitral valvuloplasty in the US, we have reported trends of decreasing overall utilization and increasing procedural complication rates and cost over a period of 13 years.Copyright � 2014 Elsevier Inc. All rights reserved.
520			_aMETHODS: Utilizing the nationwide inpatient sample database from 1998 to 2010, we identified patients using the International Classification of Diseases, 9th Revision, Clinical Modification procedure code for "percutaneous valvuloplasty." Patients >18 years of age with mitral stenosis were included. Patients with concomitant aortic, tricuspid, or pulmonic stenosis were excluded. Primary outcome included death and procedural complications.
520			_aRESULTS: A total of 1308 balloon mitral valvuloplasties (weighted n = 6540) were analyzed. There was a 7.5% decrease in utilization of the procedure from 24.6 procedures/10 million population in 1998-2001 to 22.7 procedures/10 million population in 2008-2010 (P for trend = .098). We observed a 15.9% overall procedural complication rate and 1.7% mortality rate. The procedural complication rates have increased in recent years (P = .001), corresponding to increasing age and burden of comorbidities in patients. The mean cost per admission for balloon mitral valvuloplasty has gone up significantly over the 10 years, from _11, 668 +/- 1046 in 2001 to _23, 651 +/- 301 in 2010 (P <.001).
546			_aEnglish
650			_a*Balloon Valvuloplasty/ut [Utilization]
650			_a*Hospitalization/ec [Economics]
650			_a*Mitral Valve Stenosis/th [Therapy]
650			_aAge Distribution
650			_aBalloon Valvuloplasty/ae [Adverse Effects]
650			_aBalloon Valvuloplasty/ec [Economics]
650			_aBalloon Valvuloplasty/td [Trends]
650			_aComorbidity
650			_aContinental Population Groups/sn [Statistics & Numerical Data]
650			_aCross-Sectional Studies
650			_aDatabases, Factual
650			_aFemale
650			_aHospital Mortality
650			_aHumans
650			_aLength of Stay/sn [Statistics & Numerical Data]
650			_aLength of Stay/td [Trends]
650			_aMale
650			_aMedicaid
650			_aMedicare
650			_aMiddle Aged
650			_aMitral Valve Stenosis/ep [Epidemiology]
650			_aUnited States/ep [Epidemiology]
651			_aMedStar Washington Hospital Center
656			_aMedicine/General Internal Medicine
657			_aJournal Article
700			_aChothani, Ankit
790			_aAlfonso C, Arora S, Badheka AO, Bhalara V, Chothani A, Cohen MG, de Marchena E, Desai H, Deshmukh A, Ghatak A, Grines C, Grover P, Kar S, Makkar R, Mehta K, O'Neill W, Palacios IF, Panaich SS, Patel N, Patel NJ, Rathod A, Rihal CS, Savani GT, Schreiber T, Shah N, Singh V
856			_uhttp://dx.doi.org/10.1016/j.amjmed.2014.05.015 _zhttp://dx.doi.org/10.1016/j.amjmed.2014.05.015
942			_cART _dArticle
999			_c1171 _d1171